A novel tool for veterinary bone regeneration
Lead Research Organisation:
University of Glasgow
Department Name: School of Engineering
Abstract
Abstracts are not currently available in GtR for all funded research. This is normally because the abstract was not required at the time of proposal submission, but may be because it included sensitive information such as personal details.
Organisations
| Description | We have now a market report for the use of bone regeneration acellular strategies in veterinary applications. This report will be useful to decide on spinning out of a new company. |
| Exploitation Route | The report will be use as part of a business case that we are putting together to attract additional resources from investors to the technology |
| Sectors | Healthcare |
| Description | Findings have been used to inform a business case that is currently being presented to investors. |
| First Year Of Impact | 2021 |
| Sector | Healthcare |
| Impact Types | Economic |
| Title | TECHNOLOGY MARKET ASSESSMENT AND PATENT LANDSCAPE ANALYSIS FOR A NOVEL TOOL FOR BONE REGENERATION |
| Description | Through BBSRC-funded and co-funded research, a research team at the University of Glasgow (the 'Client') has achieved extremely promising results for an ultralow-dose growth factor technology ("HealiOst"). The technology yields high bioactivity based on a simple polymer (poly(ethyl acrylate) (PEA))-based material, driving efficient stem cell differentiation and bone regeneration in a critical-sized mouse defect model, with translation to a clinical veterinary setting ongoing. IP Pragmatics Ltd. (IPP) has been commissioned (using Pathfinder funding) by the Client to perform a comprehensive market assessment of the technology |
| Type Of Material | Technology assay or reagent |
| Year Produced | 2019 |
| Provided To Others? | No |
| Impact | The report will inform on future applications and developments towards commercialisation of the technology. |